BOTHELL,
Wash., July 27, 2023 /PRNewswire/ -- BioLife
Solutions, Inc. (NASDAQ: BLFS), a leading supplier of
class-defining bioproduction tools and services for the cell and
gene therapies ("CGT") and broader biopharma markets, today
announced the Company's second quarter financial results will be
released after market close on Tuesday,
August 8, 2023. The Company will host a conference call and
live webcast at 4:30pm ET
(1:30pm PT) that day. Management will
provide an overview of the Company's financial results and a
general business update.
To access the webcast, log onto the Investor Relations page of
the BioLife Solutions website
at https://www.biolifesolutions.com/earnings. In
addition, the conference call will be accessible by dialing
toll-free (800) 715-9871. The conference ID number is 6684703. A
webcast replay will be available approximately two hours after the
call and will be archived
on https://www.biolifesolutions.com/ for 90 days.
About BioLife Solutions
BioLife Solutions is a leading
supplier of class-defining bioproduction tools and services for the
cell and gene therapy and broader biopharma markets. Our tools
portfolio includes our
proprietary CryoStor® and
HypoThermosol® biopreservation media for shipping
and storage, the ThawSTAR® family of automated,
water-free thawing products, evo® cold chain
management system, high capacity cryogenic
controlled-rate freezers, Stirling Ultracold mechanical
freezers, SciSafe biologic storage services, and Sexton
Biotechnologies cell processing tools. For more information,
please visit www.biolifesolutions.com or follow BioLife on
Twitter.
Media & Investor Relations
At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com
Investors
LHA Investor Relations
Jody Cain
(310) 691-7100
jcain@lhai.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-provide-second-quarter-2023-financial-results-and-business-update-on-august-8-2023-301887523.html
SOURCE BioLife Solutions, Inc.